ROIV - BioTech reporting 2/13 as a LONG earnings trade
Mis à jour
Roivant Scientes, on the 15 minute chart is experiencing increase volatility and volume now two
days out from its earnings report. The MACD with zero lag shows a bullish inflection in the lines
On the daily chart, ROIV gained 38% in 2023 but has been down 4 %YTD. The volume and
volatility show both are heightened in the pre-earnings run- up. The last report in November
was a double beat which is good prognosis for the one upcomings. This is a risky earnings
play, ROIV does not yet make money. However, because it lost less than forecasted, buyer
interest has increased. The call option for 2/16 for a strike of $12.50 is priced at $ 5.00
per contract. I suspect a long trade in shares may gain to $ 11.50 targeting the double top
at the turn of the year for a projected gain upside of about 7% (with a stop loss of 2.5%).
Considering that ROIV has gained 12% this past week, 7% in the next two days is about the
same trend angle. As to the call contract, I have considered 100% return as my expections
for the two days before the earnings. If earnings disappoint trader expectations and price fades
I will sell to close the contract. If earnings is as expected, I will roll the contract forward into
the March monthly and add a bit more capital into the trade.
days out from its earnings report. The MACD with zero lag shows a bullish inflection in the lines
On the daily chart, ROIV gained 38% in 2023 but has been down 4 %YTD. The volume and
volatility show both are heightened in the pre-earnings run- up. The last report in November
was a double beat which is good prognosis for the one upcomings. This is a risky earnings
play, ROIV does not yet make money. However, because it lost less than forecasted, buyer
interest has increased. The call option for 2/16 for a strike of $12.50 is priced at $ 5.00
per contract. I suspect a long trade in shares may gain to $ 11.50 targeting the double top
at the turn of the year for a projected gain upside of about 7% (with a stop loss of 2.5%).
Considering that ROIV has gained 12% this past week, 7% in the next two days is about the
same trend angle. As to the call contract, I have considered 100% return as my expections
for the two days before the earnings. If earnings disappoint trader expectations and price fades
I will sell to close the contract. If earnings is as expected, I will roll the contract forward into
the March monthly and add a bit more capital into the trade.
Transaction en cours
Sideways for now. Full position.Transaction en cours
Price is holding up on a down market day.Clause de non-responsabilité
Les informations et les publications ne sont pas destinées à être, et ne constituent pas, des conseils ou des recommandations en matière de finance, d'investissement, de trading ou d'autres types de conseils fournis ou approuvés par TradingView. Pour en savoir plus, consultez les Conditions d'utilisation.